clinical trial · NCT04373369
Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Extensive-stage Small Cell Lung CancerVorolanibAtezolizumab
brief summary
The purpose of the study is to determine whether adding vorolanib to atezolizumab will improve the length of time that participants are cancer-free after receiving standard chemotherapy.
started
Oct 7, 2020
primary completion
Aug 18, 2022
completion
Aug 11, 2025
last updated
Nov 3, 2025
official title
A Phase II Study of Maintenance Vorolanib and Atezolizumab in Patients With Extensive-stage SCLC
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol